Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia

Article

关键词: NITRIC-OXIDE SYNTHASE;    ACTIVATED RECEPTOR-GAMMA;    PPAR-GAMMA;    HYPERTENSION;    INDUCTION;    REGULATOR;    INSULIN;    GROWTH;    GENE;   

DOI  :  10.1161/hc3001.092040

来源: SCIE

【 摘 要 】

Background-Cytokines induce apoptosis in vascular disease lesions through enhancement of inducible nitric oxide (NO) synthase (iNOS) activation. The thiazolidinediones, novel insulin-sensitizing agents, have been demonstrated to modulate cytokine-induced NO production. We have investigated the role of pioglitazone in the apoptosis of vascular smooth muscle cells (VSMCs) in vitro and developed intimal. hyperplasia in vivo. Methods and Results-Pioglitazone (0.1 to 10 mu mol/L) significantly enhanced cytokine-induced expression of iNOS and NO production in a dose-dependent mariner in rat VSMCs, but 15-deoxy-Delta (12,14)-prostaglandin J2 (up to 10 mu mol/L), a native peroxisome proliferator-activated receptor-gamma ligand, showed no effect. Pioglitazone also significantly enhanced reduction of cell viability, as evidenced by the increase in the number of TUNEL-positive cells. All of these effects of pioglitazone were blocked by treatment with N-monomethyl-L-arginine, an NO synthesis inhibitor. In an in vivo study with a balloon-injured rat carotid artery, neointimal thickness had reached maximum levels at 2 weeks after injury. Then, rats were fed with or without pioglitazone (3 mg.kg(-1).d(-1)) for an additional week. The ratio of intima to media area of carotid artery was significantly decreased by 30%, and the ratio of apoptotic cells in neointima was significantly increased in pioglitazone-treated rats compared with vehicle-treated control rats. Conclusions-Pioglitazone enhanced apoptosis in an NO-dependent manner in cytokine-activated VSMCs and induced significant regression of intimal hyperplasia in balloon-injured rat carotid artery. It appears that pioglitazone is a potent apoptosis inducer in vascular lesions, providing a novel pharmacological strategy to prevent restenosis after vascular intervention.

【 授权许可】

Free